Marcy l’Etoile, France – bioMérieux, a world leader in the field of in vitro diagnostics, announces that it has entered into an agreement to acquire BioFire Diagnostics Inc., a privately held U.S.-based company specialized in molecular biology. BioFire invented, manufactures and commercializes its multiplex PCR FilmArray® system, a simple and rapid molecular biology solution dedicated […]
Newton, MA – Bodkin Design and Engineering LLC (BD&E), is an electro-optic systems and solutions research and design firm that develops innovative, cost effective optical sensing products for medical device, diagnostic, life science, and biotechnology industries. The prototype immunoassay platform was developed in collaboration with Boston University and Zoíray Technologies, Inc. The novel assay design […]
MURRIETA, Calif. — The Hamilton Regional Laboratory Medicine Program, one of the largest lab networks in Canada, serving more than 1.4 million residents across the Hamilton Niagara Haldimand Brant Local Health Integration Network (HNHB LHIN), announced today the decision to purchase COPAN’s WASPLab, the latest generation of full laboratory automation and digital microbiology system. Installation […]
MEXICO CITY — Ariosa Diagnostics announced the offering of its Harmony™ Prenatal Test in Mexico through a partnership with Advance Medical on August 22, making the Latin American nation with over 2 million live births one of 46 countries around the world where the Harmony Prenatal Test can be ordered by healthcare providers. The Harmony […]
Baltimore, MD – BD Diagnostics, a segment of BD (Becton, Dickinson and Company), announced today the availability of the CE-marked BD MAX™ StaphSR assay with eXTended Detection Technology in Europe for use on the fully-automated BD MAX™ System. The assay with eXTended detection accurately identifiesStaphylococcus aureus and methicillin-resistant Staphylococcus aureus (MRSA) from nasal swabs in […]
Basel – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that a new injectable (subcutaneous) formulation of Herceptin (trastuzumab) has been approved by the European Commission for the treatment of HER2-positive breast cancer, an aggressive sub-type of the disease. The approval is for both early and later stages of treatment. “More than 90,000 women in […]
GLOSTRUP, Denmark – Dako, an Agilent Technologies Company and worldwide provider of cancer diagnostics, and Omnyx, LLC (a joint venture of GE Healthcare and the University of Pittsburgh Medical Center) a leader in digital pathology, announced today that they are launching clinical image analysis for digital pathology in Europe. By providing quantitative results for HercepTest, […]
WALTHAM, Mass.– PerkinElmer, Inc., a global leader in improving the health and safety of people and the environment, today introduced the first commercially available screening test for Severe Combined Immunodeficiency(SCID). The EnLite™ Neonatal TREC System expands the newborn screening portfolio of commercially available tests and will be introduced under CE marking, for sale in select […]
BD Rx Inc., a wholly-owned subsidiary of leading global medical technology company BD (Becton, Dickinson and Company) (NYSE:BDX), announced today that the U.S. Food and Drug Administration (FDA) has approved the third drug to be offered in the new BD Simplist™ line of ready-to-administer prefilled generic injectables. The third BD Simplist product to launch is […]
SUNNYVALE, Calif.,– Cepheid (NASDAQ: CPHD) today announced the U.S. Food & Drug Administration (FDA) has categorized Cepheid’s Xpert®MTB/RIF test as ‘Moderate Complexity’ under the Clinical Laboratory Improvement Amendments (CLIA). Xpert MTB/RIF is designed for the rapid molecular detection ofMycobacterium tuberculosis complex (MTB-complex) DNA and, in specimens where MTB-complex DNA is detected, Xpert MTB/RIF also detects […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
